Latest news

Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals

A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.
Read more